Scientific Award AstraZeneca Foundation in Cancer as a Systemic Disease: Insights on Organ Crosstalk

The AstraZeneca Foundation attaches great importance to promoting scientific research. On the initiative of the AstraZeneca Foundation, the FWO and the F.R.S.-FNRS will give in 2026 a scientific award in recognition of innovative scientific research related to cancer as a systemic disease: insights on organ crosstalk.

• Prize amounting to 25,000 EURO.
• Rewards innovative scientific research that elucidates systemic hallmarks of cancer and inter-organ communication networks shaping tumor initiation, progression, organotropism/metastasis, treatment response/resistance, and cancer-associated conditions.
• The prize is intended to reward an established investigator on the basis of their previous work, with a perspective of future development in the same field.

• You have a PhD.
• The applicant must have obtained their first PhD degree maximum 15 years before the date of the submission deadline (possibly extended in case of eligible career breaks, see regulations).
• The award can only be given to an individual scientist from postdoctoral level onwards who is affiliated to a Belgian university, a university hospital or an eligible resarch institute (see regulations). Prior to the submission deadline, the applicant must have held a research position in Belgium for at least five years (in a consecutive or cumulated period).

• Submit your candidacy using the appropriate form, filled in correctly and completely (in English), on 04 May 2026 midnight CEST at the latest.
• Your candidacy is submitted to a jury.
• The jury selects one laureate for the prize.
• The laureate attends the awards ceremony, which will take place in the evening of 10 December 2026 at the Palace of the Academies (Brussels).